Kev piav qhia
Raws li cov khoom tseem ceeb hauv cov txheej txheem tsim khoom Vonoprazan, Vorolazan Intermediate 5 plays lub luag haujlwm tseem ceeb hauv kev ua kom muaj txiaj ntsig thiab kev ntseeg siab ntawm cov khoom kawg.Nws cov qauv tshuaj tshwj xeeb 5-(2-fluorophenyl)-N-methyl-1-(3-pyridylsulfonyl)-1H-pyrrole-3-methylamine distinguishes nws los ntawm lwm yam intermediates thiab ua rau nws los ua ib qho tseem ceeb muaj nyob rau hauv lub tuam txhab kws tshuaj.
Nyob rau hauv peb lub xeev-of-the-art chaw tsim khoom, peb ua raws li cov qauv zoo tshaj plaws los tsim Vorolazan Intermediate 5. Peb cov kev tswj xyuas nruj kom ntseeg tau tias txhua pawg ua tau raws li cov qauv nruj tshaj plaws ntawm purity, stability thiab sib xws.Qhov no ua kom peb cov neeg siv khoom tau txais cov khoom lawv tuaj yeem ntseeg tau thiab tso siab rau lawv cov kev xav tau ntau lawm.
Xaiv Peb
JDK muaj cov chaw tsim khoom thawj zaug thiab cov cuab yeej tswj kev ua haujlwm zoo, uas ua kom muaj kev ruaj khov ntawm API intermediates.Pab neeg tshaj lij paub tseeb R & D ntawm cov khoom.Tawm tsam ob qho tib si, peb tab tom nrhiav rau CMO & CDMO hauv kev lag luam hauv tsev thiab thoob ntiaj teb.